Skip to content

Axogen AXGN Investment Purchases

Investment Purchases at other companies

IAR
Integra LifeSciencesIART
$0-100%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$150.87M+5,115%
Medtronic logo
MedtronicMDT
$2.15B+0.9%

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.26B+110%
Enterprise value$2.2B+91.4%
P/S9.5×+4.0×

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's investment purchases?
Axogen (AXGN) reported investment purchases of $19M in Q1 2026.
What is the long-term trend for Axogen's investment purchases?
Over 3 years (2021 to 2025), Axogen's investment purchases has grown at a -41.5% compound annual growth rate (CAGR), from $68.7M to $13.72M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.